Document is current
Any future updates will be listed below
-
Authors
Chillà, Anastasia
Anceschi, Cecilia
Scavone, Francesca
Martinelli, Serena
Ruzzolini, Jessica
Frediani, Elena
Margheri, Francesca
Tahir, Tahir
Concas, Guilherme C.
Gisbert, Mariana
Cremona, Marco
Freire, Fernando
Aucélio, Ricardo Q.
Pierre, Tatiana Saint
Rossi, André L.
Severi, Mirko
Traversi, Rita
Bani, Daniele
Guasti, Daniele
Daldosso, Nicola
Del Rosso, Mario
Fibbi, Gabriella
SantAnna, Celso
Del Rosso, Tommaso
Laurenzana, Anna
-
Funding
Funding for this research was provided by:
FAPERJ (E-26/211.540/2021)
FAPERJ (E-26/211.540/2021)
FAPERJ (E-26/211.540/2021)
FAPERJ (E-26/210.140/2019)
FAPERJ (E-26/211.180/2019)
Associazione Italiana per la Ricerca sul Cancro (IG 2020 N. 24381)
Regione Toscana (Therminator)
NextGenerationEU and Ministry of Enterprises and Made in Italy (Fatale)
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 17 August 2025
First Online: 26 August 2025
Declarations
:
: All animal procedures were conducted in compliance with ethical standards, adhering to the Declaration of Helsinki and national regulations. Approval was granted by the Ethical Committee of the Animal Welfare Office of the Italian Health Ministry (Authorization No. 326/2022-PR). All procedures conformed to legal mandates and Italian guidelines for the care and maintenance of laboratory animals. The isolation and utilization of stem cells from umbilical cord blood for research purposes are authorized under Italian law, contingent upon obtaining informed consent (R711-D) from the mothers, as stipulated in Article 2, Paragraph 1, Letter f of the decree issued on November 18, 2009.
: Not applicable.
: The authors declare no potential conflicts of interest.
